INVO Bioscience Inc (INVO)
0.90
+0.01
(+1.12%)
USD |
NASDAQ |
May 28, 11:44
INVO Bioscience Accounts Payable (Quarterly)
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 2.330M |
September 30, 2023 | |
June 30, 2023 | |
March 31, 2023 | 1.847M |
December 31, 2022 | 1.349M |
September 30, 2022 | |
June 30, 2022 | |
March 31, 2022 | |
December 31, 2021 | 0.4434M |
September 30, 2021 | 0.5156M |
June 30, 2021 | 0.3063M |
Date | Value |
---|---|
March 31, 2021 | 0.512M |
December 31, 2020 | 0.3289M |
September 30, 2020 | 0.456M |
June 30, 2020 | 0.3095M |
March 31, 2020 | 0.2947M |
December 31, 2019 | 0.3715M |
September 30, 2019 | 0.4574M |
June 30, 2019 | |
March 31, 2019 | |
December 31, 2018 | 0.5718M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.2947M
Minimum
Mar 2020
2.330M
Maximum
Dec 2023
0.7325M
Average
0.456M
Median
Sep 2020
Accounts Payable (Quarterly) Benchmarks
Abbott Laboratories | 4.178B |
Perspective Therapeutics Inc | 6.027M |
Xtant Medical Holdings Inc | 7.378M |
Asensus Surgical Inc | 4.036M |
Catheter Precision Inc | 0.543M |